Brandon Imber, MD, MS

Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures:

Presentations

Sep 29

When, How, and Why Should We Use Very Low Dose RT in Indolent Lymphomas?
08:17am - 08:32am PT
Sep 30

331 - Prospective Study of Split-Course Bridging Radiotherapy (SC-BRT) Prior to CAR T-Cells for Relapsed/Refractory B-Cell Lymphomas
02:50pm - 03:00pm PT